-
-
7 . Periodical
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
- 저자
- by Broome, Catherine M; McDonald, Vickie; Miyakawa, Yoshitaka; Carpenedo, Monica; Kuter, David J, et al.
- 소스
- The Lancet; 20230101, Issue: Preprints